172 studies found for:    "Children's Hospital of Wisconsin"
Show Display Options
Rank Status Study
21 Recruiting Treosulfan and Fludarabine Phosphate Before Donor Stem Cell Transplant in Treating Patients With Nonmalignant Inherited Disorders
Condition: Nonmalignant Neoplasm
Interventions: Drug: treosulfan;   Drug: fludarabine phosphate;   Biological: anti-thymocyte globulin;   Radiation: total-body irradiation;   Procedure: allogeneic bone marrow transplantation;   Procedure: peripheral blood stem cell transplantation;   Procedure: umbilical cord blood transplantation;   Drug: tacrolimus;   Drug: methotrexate;   Drug: cyclosporine;   Drug: mycophenolate mofetil;   Other: laboratory biomarker analysis
22 Recruiting Congenital Sucrase-Isomaltase Deficiency (CSID) Genetic Prevalence Study (GPS)
Condition: Congenital Sucrase-isomaltase Deficiency (CSID)
23 Terminated Open-label Extension to Protocol 1042-0500
Condition: Infantile Spasms
Intervention: Drug: Ganaxolone
24 Enrolling by invitation The Use of L-Carnitine And CoQ10 Supplements In the Treatment of Cyclic Vomiting Syndrome (CVS)
Condition: Cyclic Vomiting Syndrome
25 Active, not recruiting Parenting After Infant Congenital Heart Defect Diagnosis
Condition: Congenital Heart Disease
26 Completed A Study of Erwinaze Administered Intravenously in Patients Who Had an Allergy to Frontline Asparaginase Therapy
Conditions: Acute Lymphoblastic Leukemia;   Lymphoblastic Lymphoma
Intervention: Drug: asparaginase Erwinia chrysanthemi
27 Recruiting Genetic Variations in Toll-like Receptors and Susceptibility to Chronic Lung Disease in Very Low Birth Weight Babies
Condition: Chronic Lung Disease
Intervention: Genetic: gene variations
28 Completed
Has Results
Optimal Platelet Dose Strategy for Management of Thrombocytopenia
Condition: Thrombocytopenia
Interventions: Procedure: Medium Dose Prophylactic Platelet Transfusions;   Procedure: Lower Dose Prophylactic Platelet Transfusions;   Procedure: Higher Dose Prophylactic Platelet Transfusions
29 Recruiting CALIPSO: Calfactant for Acute Lung Injury in Pediatric Stem Cell Transplant and Oncology Patients
Condition: Acute Lung Injury
Interventions: Drug: Calfactant;   Other: Air placebo
30 Completed Triptorelin for Ovary Protection in Childhood Onset Lupus
Condition: Systemic Lupus Erythematosus
Intervention: Drug: Triptorelin pamoate
31 Completed
Has Results
Pharmacokinetics and Safety of ORF Tablets in Pediatric Patients
Condition: Opioid Analgesia
Intervention: Drug: Oxycodone hydrochloride controlled-release (ORF) tablets
32 Completed Trial of Montelukast for Treatment of Acute Bronchiolitis
Condition: Bronchiolitis
Interventions: Drug: montelukast sodium;   Other: sucrose
33 Recruiting A Retrospective, Observational, Noninterventional Data Collection Study for Patients With Molybdenum Cofactor Deficiency Who Have Been Previously Treated With Cyclic Pyranopterin Monophosphate (cPMP)
Condition: Molybdenum Cofactor Deficiency
34 Active, not recruiting Phase 3 Study of Aztreonam for Inhalation Solution (AZLI) in a Continuous Alternating Therapy Regimen for the Treatment of Chronic Pseudomonas Aeruginosa Infection in Patients With CF
Condition: Cystic Fibrosis
Interventions: Drug: Aztreonam for Inhalation Solution (AZLI);   Drug: Placebo
35 Completed Transition From Hospital to Home in Solid Organ Transplant (SOT)
Condition: Solid Organ Transplant
36 Recruiting Discharge to Home and Chronic Illness Care Pilot
Condition: Solid Organ Transplant
Intervention: Behavioral: myFAMI iPad application
37 Completed Effect of Early Rest on Recovery From Pediatric Concussion
Conditions: Mild Traumatic Brain Injury;   Concussion;   Post-concussive Syndrome
Intervention: Behavioral: Mandated Rest, Intervention
38 Completed Epidemiologic Multicenter Study on Mechanical Ventilation Management in Children With Acute Lung Injury
Conditions: Acute Lung Injury;   Acute Respiratory Distress Syndrome
39 Recruiting Peripheral Blood Stem Cell Transplantation Using the CliniMACS Device
Conditions: Malignant Diseases (ie, Leukemia, MDS, Lymphoma);   Non-malignant Diseases (ie, Bone Marrow Failure Syndromes)
Interventions: Device: CliniMACS (CD+3, CD+19 depletion);   Device: CliniMACS (CD 34+ positive selection)
40 Completed
Has Results
An Open-Label Extension Study of GA-GCB ERT in Patients With Type 1 Gaucher Disease
Condition: Gaucher Disease, Type 1
Intervention: Biological: VPRIV®

Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results
Indicates status has not been verified in more than two years